GENE ONLINE|News &
Opinion
Blog

MSD
Merck Launches $1 Billion Vaccine Facility in North Carolina, Boosting U.S. Manufacturing and Job Creation
2025-03-13
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Merck Joins Forces with Daiichi Sankyo in $5.5 Billion Deal to Develop Cancer Drugs
2023-10-22
World Premiere of Documentary-style Film on the Battle Against Antibiotic Resistance
2023-09-06
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Keytruda Receives Two New Approvals in Japan
2020-08-30
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
HIV
Weekly in Asia 2019|AUG-1
2019-08-17
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top